Nara Organics has initiated a voluntary recall of all lots of its powdered infant formula following reports of three infants being hospitalized with botulism. The illnesses have been linked to consumption of the product, according to company statements and public health advisories.
The recalled formula was distributed nationwide and was available for purchase through Target stores, Target.com, and Nara.com. Sales of the affected product occurred between July 2025 and June 2026. The company has not reported any deaths associated with the outbreak in the available coverage.
Public health officials are advising caregivers to immediately stop using the recalled Nara Organics powdered infant formula. Parents and guardians are urged to seek prompt medical attention if an infant exhibits symptoms of botulism after consuming the product. Symptoms can include poor feeding, difficulty swallowing, muscle weakness, and changes in the infant’s cry. Respiratory distress and constipation can also be indicators.
Botulism is a rare but serious illness caused by a toxin produced by the bacterium Clostridium botulinum. In infants, it is often associated with the ingestion of spores, which can be found in dust and soil, and sometimes in food products. The toxin affects the nervous system, leading to muscle paralysis. Prompt diagnosis and treatment with an antitoxin are crucial for recovery.
While the distribution channels for the recalled formula were national, local health departments have been alerted to provide guidance to residents. Information on safe disposal of the recalled product and where to seek medical evaluation for infants who may have consumed it has been disseminated. The recall underscores the critical importance of vigilance in the manufacturing and distribution of infant nutrition products.
Nara Organics has stated it is cooperating fully with health authorities and is working to implement enhanced safety protocols. The company has provided contact information for consumers seeking further details about the recall and reimbursement for purchased products.
This incident highlights the vulnerabilities in the supply chain for essential infant products and the need for stringent quality control measures. The swift action by Nara Organics to recall the product, coupled with public health advisories, aims to mitigate further risk to infants across the country. The investigation into the source of the contamination is ongoing, with a focus on the manufacturing process and raw ingredient sourcing.
Caregivers are reminded that while this information is provided for public awareness, it is not a substitute for professional medical advice. Any concerns regarding an infant’s health should be directed to a qualified healthcare provider. The symptoms of botulism can be subtle and may worsen rapidly, necessitating immediate medical evaluation if suspected.
